IMSS destinó $113 mil millones a atención de enfermedades crónicas en 2025
Why This Matters
The IMSS's allocation of over 113 billion pesos to chronic disease care in 2025 underscores the significant financial burden of managing these conditions in Mexico, highlighting the need for effective preventive measures and treatment strategies. This substantial investment also underscores the country's growing healthcare challenges, which are likely to strain the IMSS's finances in the future. The allocation's magnitude underscores the importance of prioritizing chronic disease management in Mexico's healthcare policy.
El Instituto Mexicano del Seguro Social (IMSS) destinó en 2025 más de 113 mil millones de pesos a la atención de seis enfermedades crónicas: diabetes, hipertensión, enfermedad renal crónica y los cánceres de mama, próstata y cérvico uterino. El monto equivale a 20.4 por ciento de los ingresos del Seguro de Enfermedades y Maternidad (SEM) y es uno de los múltiples factores que presionan las finanzas institucionales.
Curation & Context
This page summarizes a public news report from jornada.com.mx. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.